Blood Coagulation and Fibrinolysis

短名Blood. Coagul. Fibrinolysis.
Journal Impact1.00
国际分区HEMATOLOGY(Q4)
期刊索引SCI Q4中科院 4 区
ISSN0957-5235, 1473-5733
h-index79
国内分区医学(4区)医学血液学(4区)

Blood Coagulation & Fibrinolysis is an international fully refereed journal that features review and original research articles on all clinical, laboratory and experimental aspects of haemostasis and thrombosis. The journal is devoted to publishing significant developments worldwide in the field of blood coagulation, fibrinolysis, thrombosis, platelets and the kininogen-kinin system, as well as dealing with those aspects of blood rheology relevant to haemostasis and the effects of drugs on haemostatic components

期刊主页投稿网址
涉及主题医学内科学生物化学心理学生物化学外科精神科免疫学遗传学血小板病理内分泌学心脏病学凝结物理血栓形成胃肠病学
出版信息出版商: Lippincott Williams and Wilkins出版周期: Bimonthly期刊类型: journal
基本数据创刊年份: 1990原创研究文献占比88.24%自引率:0.00%Gold OA占比: 7.95%
平均审稿周期 网友分享经验:偏慢,4-8周
平均录用比例网友分享经验:容易

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

Improved prevention of bleeding episodes with emicizumab in 3 patients with concomitant hemophilia A and von Willebrand disease

2024-9-5

Protein S contributes to the paradoxical increase in thrombin generation by low-dose dabigatran in the presence of thrombomodulin

2024-8-23

Cancer-associated thrombosis: the role of inherited thrombophilia

2024-7-26

Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey

2024-7-24

Joint deficiency of coagulation factors VII and IX: a case report

2024-7-17

Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience

2024-7-16

Effect of hemolysis on D-dimer testing measured with the Improgen kit: is all manufacturer information correct?

2024-7-4

COVID-19 vaccination prevents venous thrombosis in patients with SARS-CoV-2 infection and thereafter

2024-7-1

Efficacy and relative safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: a systematic review and meta-analysis

2024-6-10

Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency

2024-6-10

Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score

2024-6-4

Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review

2024-5-23

Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy

2024-5-22

The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma

2024-5-20

Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates

2024-5-10

Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans

2024-5-9

Concurrent congenital hemophilia B and acquired hemophilia A: a unique case report

2024-5-2

To do or not to do mixing study in the era of integrated testing for lupus anticoagulant

2024-5-2

Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays

2024-4-29

Uvaol alleviates oxidative stress induced human umbilical vein endothelial cell injury by suppressing mitogen-activated protein kinase signaling pathway

2024-4-26

Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis

2024-4-17

Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study

2024-4-16

Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis

2024-4-4

Sustained good response to rituximab in acquired von Willebrand syndrome

2024-4-1

Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays

2024-4-1

Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease

2024-3-26

Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type

2024-3-20

A rare case of essential thrombocythemia with pseudo-hyperkalemia

2024-3-13

Characteristics of factor V and protein C based on results from Korean testing centers

2024-3-13

Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits

2024-3-11

Frequency, clinical, and laboratory findings of platelet secretion disorders in patients referred to the specialized coagulation laboratory of the Iranian Blood Transfusion Organization

2024-3-11

Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population

2024-2-29

Utilization and safety of off-label prothrombin complex concentrate (4F-PCC) in a nonsurgical population

2024-2-29

How complicated can be a case with immune thrombocytopenic purpura?: postsplenectomy arterial thrombosis

2024-2-22

Bleeding disorders in Saudi Arabia, causes and prevalence: a review

2024-2-15

Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis

2024-2-15

Mixing studies for lupus anticoagulant: does it matter how we mix?

2024-2-14

Multiple venous thrombosis caused by F9 gene duplication and treated with catheter-directed thrombolysis, AngioJet-assisted pharmaco-mechanical thromboectomy and manual aspiration thromboectomy

2024-2-14

Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding

2024-2-14

In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant

2024-2-14

Thrombopoietin receptor agonist and rituximab combination therapy in patients with refractory primary immune thrombocytopenia

2024-2-14

The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage

2024-2-12

Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma

2024-2-7

Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers

2024-2-2

The link between high factor VIII to protein C ratio values and poor liver function after major hepatectomy

2024-1-30

Falsely prolonged prothrombin time test in a patient with erythrocytosis: a case report

2024-1-25

Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia

2024-1-19

Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report

2023-12-20

Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience

2023-12-20

Exploring antithrombin: insights into its physiological features, clinical implications and analytical techniques

2023-12-15

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司